Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD20 Rituximab297 anti-Human, BV650, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™

Catalog No. BDB756468 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB756468 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB756468 Supplier BD Biosciences Supplier No. 756468
Only null left
Add to Cart
Add to Cart

Biosimilar Monoclonal Antibody

CD20 Rituximab297 Monoclonal antibody specifically detects CD20 Rituximab297 in Human samples. It is validated for Flow cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD20 Rituximab297
Applications Flow Cytometry
Classification Monoclonal
Clone Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb)
Concentration 0.2 mg/mL
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias B1; Bp35; LEU-16; MS4A1
Immunogen Human CD20
Purification Method Affinity Chromatography
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 931
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.
Form Liquid
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.